Cardiopulmonary Bypass Completed Phase 4 Trials for Gabapentin (DB00996)

Also known as: Cardiopulmonary bypass / Bypass, Cardiopulmonary

IndicationStatusPhase
DBCOND0032101 (Cardiopulmonary Bypass)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01022736Plasma Gabapentin Concentration During and Following Cardiac BypassTreatment